KURA FY 2015 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$802M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,000

Operating Income

-$24M

Net Income

-$23M

EPS (Diluted)

$-2.28

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$87M

Total Liabilities

$5M

Stockholders' Equity

$82M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,000	-$23,907	+16.3%
Operating Income	-$24M	-$12M	-102.2%
Net Income	-$23M	-$11M	-105.4%